Загрузка...
Imatinib Mesylate for Patients With Unresectable or Recurrent Gastrointestinal Stromal Tumors: 10-Year Experience From Vietnam
Only limited data are available concerning the long-term outcomes of imatinib treatment among Vietnamese or Asian patients with unresectable or recurrent gastrointestinal stromal tumors (GISTs). Our study, which was conducted in 188 patients, aimed to assess the efficacy of imatinib mesylate against...
Сохранить в:
| Опубликовано в: : | Cancer Control |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6643187/ https://ncbi.nlm.nih.gov/pubmed/31319677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274819863776 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|